NeuroTherm Acquires ArthroCare’s Parallax and Contour Product Lines

WILMINGTON, Massachusetts, July 1, 2011 -

- Purchase further expands
NeuroTherm’s reach into the $5 Billion Global Interventional Pain
Medicine Market

NeuroTherm® announced today that they have acquired the Parallax
and Contour product lines used in interventional spine procedures
from ArthroCare (NASDAQ: ARTC). Parallax products have long been
the standard for vertebroplasty and Contour has been developed for
cavity creation.

(Logo:   href="photos.prnewswire.com/prnh/20090217/NE70925LOGO">photos.prnewswire.com/prnh/20090217/NE70925LOGO
)

“ArthroCare’s Parallax portfolio is a natural fit with
NeuroTherm’s existing competencies in interventional pain
management, allowing us to leverage our clinical expertise and
strong sales channels,” says Larry Hicks, CEO of NeuroTherm. “This
is an exciting opportunity that will enable us to expand our
customer base into new markets while offering our existing
customers more treatment options for their patients. The Parallax
and Contour product lines fit very well within NeuroTherm’s
platform for the interventional pain and radiology space and is
highly complementary to our existing product offering,” continues
Hicks.

“Consistent with previous acquisitions that have strengthened
and diversified our business, we are entering a market aligned with
demographic trends and growing medical need,” says Chris Boyer,
Vice President of Marketing. NeuroTherm actively sells
interventional pain products into 63 countries around the world.
“Vertebral compression fracture treatment is a market with
significant growth and opportunity, and we expect it to be an
important part of our continued growth plans,” continues Boyer.

NeuroTherm is a leading manufacturer of products used in the
field of Interventional Pain, including radio frequency generators
and related consumables used in the treatment of chronic pain. The
company was awarded a US Patent #7,574,257 in recognition of the
first multi-lesion radiofrequency generator on the market.
NeuroTherm markets and sells to Interventional Pain, Interventional
Radiology, Orthopedic and Foot & Ankle Specialists.

NeuroTherm is based in Wilmington, Massachusetts with corporate
offices in London, UK, Germany and Amsterdam, NL. Additional
information about NeuroTherm can be found on at href="www.neurotherm.com/">www.neurotherm.com.

Christopher Boyer, Vice President, Marketing, +1-978-657-6519, cboyer at neurotherm.com